ArticleCardiovascular and interventional radiology2026
Same-Day Radioembolization for Large Hepatocellular Carcinoma (≥ 5 cm) Using Yttrium-90 Resin Microspheres: Protocol for a Multicenter Prospective Registry Study (ISTAR-01).
Article in Cardiovascular and interventional radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06944483 (Same-day Radioembolization for Large HCC), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Same-day Radioembolization for Large HCC (>5cm) With Y90 Resin Microspheres : Multicenter Prospective Registry Study
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aims to evaluate the technical feasibility of same-day yttrium-90 (Y-90) radioembolization in patients with large hepatocellular carcinoma (HCC) (≥ 5 cm) who are predicted to have a low lung shunt fraction (LSF) based on imaging features. MATERIALS AND
methodsThis prospective, multicenter, open-label, single-arm registry study will enroll patients with large HCC without imaging features suggestive of high LSF. Eligible patients will undergo same-day planning angiography, technetium-99 m macroaggregated albumin ( STATISTICS: A total of 139 patients will be enrolled to estimate feasibility, assuming a success rate of 90% with a 5% margin of error at a 95% confidence level. ORR will be compared using the chi-square test, while PFS and OS will be evaluated using the Kaplan-Meier method and compared using the log-rank test. EXPECTED GAIN OF KNOWLEDGE: This study will provide prospective evidence regarding the feasibility and clinical outcomes of same-day radioembolization in large HCC. CLINICALTRIALS: GOV IDENTIFIER: NCT06944483.
Indexed as
Identifiers
42844316What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.